Andrea S. Blevins Primeau, PhD, MBA

Residual pathologic disease often remains after neoadjuvant chemotherapy and resection in patients with esophageal or GEJ cancers, and these patients have a high risk of recurrence.

Investigators report on findings from the MARIETTA study, which evaluated an intensive, CNS-directed chemoimmunotherapy followed by autoHSCT in patients with secondary CNS lymphoma.

A team of investigators conducted a retrospective study to determine the relationship of intrinsic breast cancer subtypes on survival in patients undergoing endocrine therapy plus ribociclib.

A team of investigators conducted a double-blind, placebo-controlled, phase 3 trial to assess outcomes following olaparib treatment in patients with BRCA 1/2-mutated, relapsed ovarian cancer.

A study was conducted to assess factors contributing to response to nivolumab treatment for advanced clear cell renal cell carcinoma.

A retrospective study was conducted to identify the relationship between Alzheimer disease or other neurocognitive disorders and previous treatment with chemotherapy for colorectal cancer.

Investigators conducted a meta-analysis to determine if breathlessness is associated with shorter survival in patients with malignant pleural effusions.

A single-arm, phase 2 trial was conducted to assess response to treatment with carfilzomib plus cyclophosphamide and dexamethasone among patients with relapsed/refractory multiple myeloma.

Investigators sought to determine if docetaxel plus cisplatin maintenance therapy was effective among Asian patients with non-small cell lung cancer.

Researchers report findings from the double-blind, phase 3 CheckMate 451 trial of nivolumab plus ipilimumab, nivolumab monotherapy, or placebo in patients with extensive-disease small cell lung cancer.